Dependence of GVL-mediating CD4+ and CD8+ T cells on perforin and Fas ligand.

被引：0
|
作者：
Hsieh, MH [1 ]
Korngold, R [1 ]
机构：
[1] Thomas Jefferson Univ, Jefferson Med Coll, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1802
引用
收藏
页码：436A / 436A
页数：1
相关论文
共 50 条
  • [41] Acthar Gel Inhibits the Activation of CD4+ and CD8+ T Cells
    Wright, Dale
    Hayes, Kyle
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2023, 43 (04): : 182 - 187
  • [42] Differences in the distribution of CD4+ and CD8+ T cells in emphysematous lungs
    Aoshiba, K
    Koinuma, M
    Yokohori, N
    Nagai, A
    RESPIRATION, 2004, 71 (02) : 184 - 190
  • [43] Differential antigen-dependency of CD4+ and CD8+ T cells
    Behrendt, A.
    Rabenstein, H.
    Ellwart, J.
    Horsch, M.
    Beckers, J.
    Obst, R.
    IMMUNOLOGY, 2012, 137 : 345 - 345
  • [44] Adoptive immunotherapy via CD4+ versus CD8+ T cells
    Vy Phan-Lai
    BIOMEDICAL RESEARCH AND THERAPY, 2016, 3 (04): : 588 - 595
  • [45] Oclacitinib depletes canine CD4+ and CD8+ T cells in vitro
    Jasiecka-Mikolajczyk, Agnieszka
    Jaroszewski, Jerzy J.
    Maslanka, Tomasz
    RESEARCH IN VETERINARY SCIENCE, 2018, 121 : 124 - 129
  • [46] Inversion of CD4+/CD8+ ratio in B chronic lymphocytic leukemia correlates with differential sensitivity of CD4+ and CD8+ T lymphocytes to the killing efficacy of Fas (APO-1/CD95) ligand+ tumor cells.
    Tinhofer, I
    Marschitz, I
    Kos, M
    Henn, T
    Egle, A
    Villunger, A
    Greil, R
    BLOOD, 1998, 92 (10) : 271B - 271B
  • [47] Abnormally differentiated CD4+ or CD8+ T cells with phenotypic and genetic features of double negative T cells in human Fas deficiency
    Rensing-Ehl, Anne
    Voelkl, Simon
    Speckmann, Carsten
    Lorenz, Myriam Ricarda
    Ritter, Julia
    Janda, Ales
    Abinun, Mario
    Pircher, Hanspeter
    Bengsch, Bertram
    Thimme, Robert
    Fuchs, Ilka
    Ammann, Sandra
    Allgaeuer, Andrea
    Kentouche, Karim
    Cant, Andrew
    Hambleton, Sophie
    da Cunha, Claudia Bettoni
    Huetker, Sebastian
    Kuehnle, Ingrid
    Pekrun, Arnulf
    Seidel, Markus G.
    Hummel, Michael
    Mackensen, Andreas
    Schwarz, Klaus
    Ehl, Stephan
    BLOOD, 2014, 124 (06) : 851 - 860
  • [48] Activated CD4+ CD25+ T cells suppress antigen-specific CD4+ and CD8+ T cells but induce a suppressive phenotype only in CD4+ T cells
    Dieckmann, D
    Plöttner, H
    Dotterweich, S
    Schuler, G
    IMMUNOLOGY, 2005, 115 (03) : 305 - 314
  • [49] Elimination of activated but not resting primary human CD4+ and CD8+ T cells by Fas ligand (FasL/CD95L)-expressing Killer-dendritic cells
    Hoves, S
    Krause, SW
    Herfarth, H
    Halbritter, D
    Zhang, HG
    Mountz, JD
    Schölmerich, J
    Fleck, M
    IMMUNOBIOLOGY, 2004, 208 (05) : 463 - 475
  • [50] Both CD4+ and CD8+ T cells are required for IFNγ, perforin, granzyme B and FasL Fas expression in islet-infiltrating cells and diabetes development in BB rats
    Suarez-Pinzon, W
    El-Sheikh, AMR
    Bleackley, RC
    Rabinovitch, A
    DIABETES, 1999, 48 : A428 - A428
12345